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Voltage-gated Ca2+ (CaV) channels enable Ca2+ influx in response to membrane
depolarization. CaV2.1 channels are localized to the presynaptic membrane of many
types of neurons where they are involved in triggering neurotransmitter release. Several
signaling proteins have been identified as important CaV2.1 regulators including protein
kinases, G-proteins and Ca2+ binding proteins. Recently, we discovered that leucine
rich repeat kinase 2 (LRRK2), a protein associated with inherited Parkinson’s disease,
interacts with specific synaptic proteins and influences synaptic transmission. Since
synaptic proteins functionally interact with CaV2.1 channels and synaptic transmission
is triggered by Ca2+ entry via CaV2.1, we investigated whether LRRK2 could impact
CaV2.1 channel function. CaV2.1 channel properties were measured using whole cell
patch clamp electrophysiology in HEK293 cells transfected with CaV2.1 subunits and
various LRRK2 constructs. Our results demonstrate that both wild type (wt) LRRK2
and the G2019S LRRK2 mutant caused a significant increase in whole cell Ca2+
current density compared to cells expressing only the CaV2.1 channel complex.
In addition, LRRK2 expression caused a significant hyperpolarizing shift in voltage-
dependent activation while having no significant effect on inactivation properties. These
functional changes in CaV2.1 activity are likely due to a direct action of LRRK2 as we
detected a physical interaction between LRRK2 and the β3 CaV channel subunit via
coimmunoprecipitation. Furthermore, effects on CaV2.1 channel function are dependent
on LRRK2 kinase activity as these could be reversed via treatment with a LRRK2 inhibitor.
Interestingly, LRRK2 also augmented endogenous voltage-gated Ca2+ channel function
in PC12 cells suggesting other CaV channels could also be regulated by LRRK2. Overall,
our findings support a novel physiological role for LRRK2 in regulating CaV2.1 function
that could have implications for how mutations in LRRK2 contribute to Parkinson’s
disease pathophysiology.
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INTRODUCTION
Voltage-gated calcium (CaV) channels play critical roles in cell signaling by enabling Ca2+
influx in response to membrane depolarization. CaV2.1 channels, composed of the pore-forming
α1A subunit and accessory β and α2δ subunits, are predominantly expressed in neuronal
(Westenbroek et al., 1998) and endocrine cells (Mahapatra et al., 2012), clustered in subcellular
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locations specialized for secretion such as the presynaptic
membrane of neurons and the secretory pole of endocrine cells.
Here, CaV2.1 channels provide a rapid, localized increase in
intracellular Ca2+ that stimulates vesicle fusion, driving the
physiological processes of neurotransmission (Qian andNoebels,
2001) and hormone release (Braun et al., 2008).
To achieve the correct spatial and temporal dynamics
required for these processes, CaV2.1 channel activity is
stringently controlled by a variety of signaling proteins that
interact with intracellular domains of the channel. These
include SNARE proteins of the secretion machinery themselves
which inhibit CaV2.1 activity to restrict Ca2+ influx to sites
of full core-complex assembly (Bezprozvanny et al., 1995;
Cohen-Kutner et al., 2010; Condliffe et al., 2010). Ca2+
binding proteins such as calmodulin (DeMaria et al., 2001),
parvalbumin and calbindin (Kreiner and Lee, 2006) also
participate in the negative feedback function of Ca2+-dependent
inactivation, down-regulating CaV2.1 activity when intracellular
Ca2+ increases. In addition, several protein kinases have been
shown to interact with CaV2.1 channel subunits to control
channel activity. These include protein kinase C (Zamponi
et al., 1997), Ca2+ calmodulin-dependent kinase II (Jiang
et al., 2008) and glycogen synthase kinase-3 (Zhu et al.,
2010). Not surprisingly, genetic defects in CaV2.1 channels
result in a variety of neurological diseases including migraine,
ataxia and epilepsy (Rajakulendran et al., 2012). While many
of these disease associated mutations result in a direct loss-
or gain-of-function of the channel, recent evidence indicates
that some mutations also disrupt regulatory interactions
with signaling proteins (Serra et al., 2010; Condliffe et al.,
2013).
Leucine rich repeat kinase 2 (LRRK2) is a large, multi-
domain protein belonging to the ROCO family of proteins.
Originally identified in screens for genes mutated in familial
Parkinson’s Disease (Paisán-Ruiz et al., 2004; Zimprich et al.,
2004), the pathophysiological effects of mutations in LRRK2
have been the focus of many studies (Li et al., 2009; Dusonchet
et al., 2011; Martin et al., 2014). In contrast, less is known
regarding the normal physiological role of LRRK2. Potential
roles have been described for autophagy (Alegre-Abarrategui
et al., 2009; Tong et al., 2010), vesicle trafficking (Piccoli
et al., 2011; MacLeod et al., 2013) and cytoskeleton dynamics
(Meixner et al., 2011; Law et al., 2014) where LRRK2 has
been shown to target important molecular components of
these pathways. A growing body of evidence also supports
a role for LRRK2 in Ca2+ signaling and homeostasis.
LRRK2 was found to activate a Ca2+/CaMKK/AMPK
pathway to increase formation of autophagosomes which
could be blocked by buffering cytosolic Ca2+ (Gómez-
Suaga et al., 2012). Cherra et al. (2013) demonstrated that
neurons expressing mutant LRRK2 had reduced cytosolic
Ca2+ buffering capacity and enhanced mitochondrial
degradation that could be restored through calcium chelation
or inhibition of CaV channels. Recently, LRRK2 was found
to up-regulate Na+/Ca2+ exchanger expression and activity
to influence Ca2+ dynamics in dendritic cells (Yan et al.,
2015).
Based on our previous work showing a presynaptic role for
LRRK2 via interactions with SNARE proteins and functional
effects on neurotransmission (Piccoli et al., 2011; Cirnaru et al.,
2014), we hypothesize that LRRK2 also targets the major
presynaptic Ca2+ influx pathway, the CaV2.1 channel, as a
further mechanism to modulate intracellular Ca2+ homeostasis.
This was investigated in the present study using patch-clamp
electrophysiology to characterize how both heterologous and
endogenous CaV channel activity is affected by expression of
various LRRK2 constructs. We further analyzed a potential
interaction between CaV channel subunits and LRRK2 via co-
immunoprecipitation.
MATERIALS AND METHODS
Cell Culture and Transfection
HEK293 cells were grown in a humidified atmosphere of 5% CO2
at 37◦C in DMEM with 10% FBS, 1% penicillin/streptomycin
and 1% glutamine. PC12 cells were maintained under the
same conditions in RPMI-1640 medium supplemented with
10% horse serum, 5% FCS and 1% penicillin/streptomycin. For
electrophysiology experiments, both cell types were plated on
glass coverslips pre-treated with poly-L-lysine. cDNA encoding
for the human CaV2.1 α1A subunit (NM_001127222) was cloned
in pEGFP-C1 to produce an α1A subunit with an EGFP tag at
the c-terminus as described previously (Condliffe et al., 2013).
In this prior study, we characterized the protein expression,
trafficking and function of the tagged channel. The rat β3 subunit
DNA (NM_001127222) was cloned in pCMV6 and rabbit α2δ1
(NM_001082276) was cloned in pcDNA3.1. At 24 h after plating,
HEK293 cells were then transfected with the EGFP-tagged
α-1A CaV2.1 channel subunit together with the accessory CaV
subunits β3 and α2δ1 in a 1:2:2 molar ratio using Lipofectamine
2000 (Invitrogen). HEK293 cells were co-transfected with wild-
type (wt) LRRK2, G2019S LRRK2 or wt LRRK1 (1:2:2:1
molar ratio; Table 1) while PC12 cells were transfected with
either EGFP alone or EGFP + wt LRRK2. Human LRRK2
(NM_198578.3) was cloned in pcDNA3.0 backbone as described
in Gloeckner et al. (2006) while human LRRK1 (NM_024652.4)
was cloned in pCMV-2×Myc vector as described in Greggio et al.
(2007).
Solutions and Reagents
To inhibit LRRK2 kinase activity in transfected HEK293 cells,
the LRRK2 kinase inhibitor LRRK2-IN-1 (Merck; Deng et al.,
2011) was added to the cell culture medium 2 h before
electrophysiological recordings at a final concentration of 1 µM.
LRRK2-IN-1 was also added to the external bath solution at
the same concentration for recordings from these pre-treated
cells. The internal patch pipette solution for both HEK293
and PC12 electrophysiological recordings contained 120 mM
CsMeSO−4 , 10 mM CsCl, 10 mM HEPES, 4 mM Mg-ATP,
3 mM Tris-GTP, 2 mM MgCl2 and 1 mM EGTA (pH
adjusted to 7.2 with CsOH). HEK293 cells were bathed in
an external solution containing 145 mM tetraethylammonium
chloride, 10 mM HEPES and 5 mM CaCl2. The external
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TABLE 1 | Biophysical properties of HEK293 cells recorded in different
experimental conditions.
Transfection/ Imax (pA) Cm (pF) Number Number of
treatment (mean ± SEM) (mean ± SEM) of cells independent
conditions experiments
CaV2.1 −396.5 ± 90.1 30.9 ± 7.1 12 5
(α1A, β3, α2δ1)
+LRRK2 −763.6 ± 97.9 31.9 ± 3.5 12 5
+LRRK1 −383.1 ± 85.7 39.3 ± 5.7 10 4
+G2019S −992.0 ± 222.0 26.6 ± 3.8 9 4
+DMSO −343.8 ± 64.3 38.5 ± 5.8 10 4
+LRRK2-IN-1 −401.5 ± 100.0 33.8 ± 6.1 10 4
solution for PC12 recordings contained 115 mM NaCl, 4 mM
KCl, 1 mM MgCl2, 10 BaCl2, 10 mM tetraethylammonium
chloride, 10 mM glucose and 10 mM HEPES. TTX was added
to this solution immediately prior to recordings at a final
concentration of 1 µM to block endogenous voltage-gated Na+
currents.
Whole Cell Patch Clamp Electrophysiology
Coverslips containing transfected HEK293 or PC12 cells were
transferred to a perfusion chamber containing the appropriate
external bathing solution mounted on an IX71 inverted
fluorescence microscope (Olympus). Whole cell CaV currents
were recorded from EGFP positive cells using patch pipettes
prepared with a P-2000 puller (Sutter) to resistances measuring
2–3 megohms when filled with internal solution. Peak whole
cell Ca2+ or Ba2+ currents were measured using an Axon
Axopatch 200B amplifier (Molecular Devices) interfaced to a
PC via a Digidata 1320 (Molecular Devices). Series resistance
was routinely compensated at 60–80% and access resistance
continually monitored during experiments where cells with
uncompensated voltage errors >5 mV were excluded from
analysis. Data were acquired at 10 kHz with leak and
capacitative transients subtracted online with a P/4 protocol
using pClamp 10.0 software. Current-voltage (I-V), activation
and inactivation curves were acquired and fit with modified
Boltzmann functions as described previously (Condliffe et al.,
2013).
Immunoblotting and
Co-Immunoprecipitation
To evaluate exogenous LRRK1, wt LRRK2, G2019S LRRK2
and CaV2.1 channel subunit protein expression in HEK293
cells as well as LRRK2 silencing in PC-12 cells, transfected
cells were solubilized in lysis buffer (150 mM NaCl, 2 mM
EDTA, 50 mM Tris-HCl, 1% NP-40 and 0.25% sodium
deoxicolate, pH 7.4) by mechanical disaggregation and protein
amount evaluated according to Bradford’s protocol. About
40 µg of total protein was diluted in 25% v/v Laemmli
buffer 5×.
For endogenous LRRK2 immunoprecipitation, littermate wt
and heterozygous BAC G2019S (Melrose et al., 2010) adult
mouse forebrains were cross-linked by incubation with 0.8%
formaldehyde solution for 2 h under agitation and then
extensively washed with cold glycine 0.1 M. Brain tissue were
then solubilized in lysis buffer (150 mM NaCl, 2 mM EDTA,
50 mM Tris-HCl, 1% NP-40 and 0.25% sodium deoxicolate,
pH 7.4) by mechanical disaggregation and protein amount
evaluated according to Bradford’s protocol. One milligram of
total protein was incubated with 3 µg of rat anti-LRRK2
(clone 24D8, generous gift from Dr. Johannes Gloeckner) or
rat anti-IgG (Abcam). Immunocomplexes were precipitated
using protein G-Sepharose beads (GE-Healthcare, Freiburg,
Germany) and eluted in Laemmli buffer at 55◦C for 10 min.
All samples were loaded onto a 10% SDS-PAGE and transferred
into nitrocellulose membrane at 82V for 2 h at 4◦C. The
primary antibodies used were: rabbit anti-LRRK2 at 1:500
(MJFF2, c41-2 Abcam), rabbit anti-calcium channel β3 subunit
1:200 (Sigma), rabbit anti-calcium channel α1a subunit 1:200
(Sigma), mouse anti-actin 1:2000, mouse anti-myc 1:1000
(Sigma), rabbit anti-S6 ribosomal protein (S6RP) 1:1000 (Cell
Signalling) applied in blocking buffer (20 mM Tris, pH 7.4,
150 mM NaCl, 0.1% Tween 20) and 5% nonfat dry milk,
overnight at 4◦C. The secondary antibody HRP-conjugated anti-
rabbit (Jackson Immunoresearch) was used at 1:7000 dilution.
Proteins were detected using the ECL detection system (GE
Healthcare).
Housing and handling of mice were done in compliance with
the guidelines established by the European Community Council
(Directive 2010/63/EU of March 4th, 2014) and approved by the
Italian Ministry of Health (IACUC 625).
Data Analysis
All data are expressed as the mean ± SEM of n experiments.
Statistical significance between two groups was determined
using an unpaired t-test at the p level indicated. ANOVA was
used for multiple comparisons with a post hoc Tukey’s test to
identify significant differences between groups at the p level
indicated.
RESULTS
LRRK2 Specifically Increases CaV2.1
Function
To determine whether LRRK2 was able to modulate CaV2.1
channel function, whole cell Ca2+ currents were recorded
from HEK293 cells co-expressing LRRK2 and CaV2.1 channel
subunits. Representative I-V traces generated using a voltage-
step protocol demonstrate that larger inward Ca2+ currents
were recorded from LRRK2 expressing cells compared to
cells transfected only with all three CaV2.1 channel subunits
(Figures 1A,B; Table 1). Comparison of the mean I-V
relationships shows an increased Ca2+ current density in
LRRK2 cells across a range of depolarized voltages (Figure 1C).
While LRRK2 increased peak current density, it did not
cause a detectable voltage shift in the I-V relationship. Peak
Ca2+ current density in both LRRK2 and control cells was
observed at 20 mV (Figure 1D), however transfection of
LRRK2 resulted in a significantly increased Ca2+ current
density at this voltage of −24.65 ± 2.81 pA/pF (n = 12)
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FIGURE 1 | LRRK2 increases CaV2.1 current density. Representative whole cell Ca2+ currents in response to a 10 mV voltage-step protocol recorded from
HEK293 cells transfected with CaV2.1 channels alone (A) or together with LRRK2 (B). (C) Mean I-V relationships of peak Ca2+ current density from CaV2.1
transfected cells in the absence (black circles) or presence (white triangles) of LRRK2 (n = 12 cells from five independent experiments). (D) Mean peak Ca2+ current
density at a holding potential of 20 mV in cells expressing CaV2.1 alone or co-expressing LRRK2 where ∗∗ indicates p < 0.01; unpaired t-test (n = 12 cells from five
independent experiments). (E) HEK293 cells were transfected with empty vector (EV) or wild-type (wt) LRRK2 and expression of LRRK2 was evaluated by
western-blotting. (F) The graph reports LRRK2 protein level normalized to the level of endogenous β-actin. Data are expressed as mean ± SEM, (n = 8).
compared to −11.76 ± 1.76 pA/pF (n = 12) in control cells.
To confirm LRRK2 overexpression, the amount of LRRK2
protein was measured via western blotting from HEK293 lysates
transfected with empty vector (EV) or LRRK2 (Figure 1E).
Normalized to endogenous β-actin expression, results show an
elevated level of LRRK2 protein in LRRK2 transfected cells
relative to EV controls (Figure 1F). Altogether, these results
demonstrate that overexpression of LRRK2 augments CaV2.1
channel function.
In addition to LRRK2, humans and other mammals
express a paralog protein, LRRK1, that has the closest
sequence homology and shares similar domain structure to
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FIGURE 2 | LRRK1 has no effect on CaV2.1 current density. (A) Mean I-V relationships of peak Ca2+ current density from HEK293 cells transfected with CaV2.1
alone (black circles; n = 10) or co-transfected with LRRK1 (gray triangles; n = 10 cells from four independent experiments). (B) Mean peak Ca2+ current density at a
holding potential of 20 mV in cells expressing CaV2.1 alone or co-expressing LRRK1. (C) Expression of myc-LRRK1, the CaV2.1 α1A subunit and β-actin in HEK293
cells transfected with EV or CaV2.1 channel subunits alone or plus myc-LRRK1 as evaluated by western-blotting. (D) Quantification of LRRK1 (black bars) and
CaV2.1 α1A subunit (red bars) protein level normalized to actin expression. Data are expressed as mean ± SEM, (n = 3).
LRRK2. However, LRRK1 is not associated with Parkinson’s
disease and has differential protein interactions suggesting it
performs distinct cellular functions from LRRK2 (Reyniers
et al., 2014). To evaluate whether LRRK2 effects on CaV2.1
channel function were specific or could also be replicated by
LRRK1, we measured whole cell CaV2.1 properties in HEK293
cells co-transfected with LRRK1. Under these conditions,
LRRK1 had no influence on current density across the
entire voltage range that was tested (Figure 2A). Peak
CaV2.1 current density was not significantly different between
cells transfected with all three CaV2.1 channel subunits or
co-transfected with LRRK1 (Figure 2B). To confirm exogenous
LRRK1 and CaV2.1 α1A subunit expression, the amount
of LRRK1 and α1A protein relative to endogenous β-actin
was measured via Western blot (Figure 2C). A robust
expression of LRRK1 and α1A was detected in LRRK1
transfected cells compared to EV controls (Figure 2D).
These results confirm that the effect of augmented CaV2.1
current is specific to LRRK2. Despite being a homologous
protein to LRRK2 in terms of sequence and structure,
LRRK1 has no impact on CaV2.1 channel function. It is
therefore possible that the effects of LRRK2 on CaV2.1 are
mediated by unique LRRK2 domains and/or protein-protein
interactions.
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The observed increase in CaV2.1 current density with
LRRK2 expression could be caused by LRRK2 increasing
CaV2.1 channel numbers at the membrane and/or direct
effects of the kinase on CaV2.1 channel gating. To provide
evidence for the latter, we tested the effects of LRRK2 co-
expression on the activation and inactivation gating properties of
CaV2.1. Figure 3A shows that LRRK2 caused a hyperpolarizing
shift in the voltage-dependence of activation curve. This was
associated with a significant hyperpolarization of the half-
activation voltage (Vhalf) from 21.08 ± 0.69 mV (n = 8)
in control cells to 16.00 ± 1.33 mV (n = 9) in LRRK2
transfected cells (Figure 3B). This data supports a role
for LRRK2 in directly regulating CaV2.1 channel gating by
increasing the proportion of activated channels at more
hyperpolarized membrane potentials. In contrast, LRRK2
had no effect on inactivation of CaV2.1. Voltage-dependent
inactivation curves for CaV2.1 were comparable between control
and LRRK2 transfected cells (Figure 3C). Also, the half-
inactivation voltage in control cells (−21.33 ± 1.13 mV,
n = 6) was not significantly different from that of LRRK2
transfected cells (−21.54 ± 2.67 mV, n = 6; Figure 3D).
In addition, we also investigated the effect of LRRK1 on
activation properties. As LRRK1 did not significantly alter
CaV2.1 current density, we hypothesized that LRRK1 would
not have any effect on CaV2.1 voltage-dependent activation.
Our results support this hypothesis showing that voltage-
dependent activation curves do not differ between control
and LRRK1 transfected cells (Figure 3E). Furthermore, no
significant difference was detected in the half-activation voltage
between control cells (−19.18 ± 1.18 mV, n = 8) and
LRRK1 transfected cells (−20.36 ± 1.43 mV, n = 10;
Figure 3F). Overall, these results indicate that LRRK2 regulates
CaV2.1 channel function via a specific effect on activation
gating.
Kinase Activity of LRRK2 is Required to
Augment CaV2.1 Function
Many of the physiological and pathophysiological roles of LRRK2
depend on its kinase activity. To determine whether the effects of
LRRK2 on CaV2.1 are linked to its kinase function, we used the
LRRK2 kinase mutant G2019S that has increased kinase activity.
This mutation enhances the ability of LRRK2 to phosphorylate
both itself and other protein substrates (West et al., 2005;
Martin et al., 2014). Therefore, if effects of LRRK2 on CaV2.1
function require kinase activity, we hypothesized that the G2019S
mutant would have enhanced effects on CaV2.1 function. To
test this hypothesis, we measured the CaV2.1 current density
in HEK293 cells co-transfected with wt or G2019S LRRK2.
I-V relationships recorded from cells co-expressing the G2019S
LRRK2 mutant exhibited an increase in CaV2.1 current density
in the voltage ranges of 10–50 mV compared to cells expressing
only the three CaV2.1 subunits (Figure 4A). Moreover, G2019S
LRRK2 increases current density further than co-expression of
wt LRRK2 (Figure 4A). Comparison of the peak CaV2.1 current
density in these three conditions confirms that G2019S LRRK2
significantly elevates CaV2.1 current (−36.50 ± 4.45 pA/pF;
n = 9) above both CaV2.1 (−9.64 ± 0.90 pA/pF; n = 10)
and wt LRRK2 (−22.72 ± 2.78 pA/pF; n = 9; Figure 4B).
Since G2019S LRRK2 had a stimulatory effect on CaV2.1 current
density, we next examined whether this was also associated with
changes to voltage-dependent activation properties. Figure 4C
shows that the voltage-dependent activation curve for CaV2.1
in the presence of G2019S has shifted to more hyperpolarized
potentials compared to controls. G2019S caused a significant
decrease in the half-activation voltage from control values of
20.11 ± 1.0 mV (n = 9) to 13.40 ± 0.61 mV (n = 9;
Figure 4D). To verify that LRRK2 protein expression was
similar between G2019S and wt and that it did not affect co-
expression levels of CaV2.1, we measured the levels of exogenous
LRRK2 and α1A expression in HEK293 cells via Western blot.
A representative blot is shown in Figure 4E which reveals
that HEK293 cells transfected with EV have minimal LRRK2
protein. However, both wt and G2019S LRRK2 transfected
cells have abundant and equivalent LRRK2 and α1A subunit
expression. Normalized to β-actin levels, wt LRRK2 expression
was not significantly different to G2019S expression (Figure 4F).
Overall, these results indicate that increased kinase activity of
LRRK2 enhances the stimulatory effect on CaV2.1 channels,
supporting a role for LRRK2 acting as a kinase to increase CaV2.1
function.
To further demonstrate that LRRK2 kinase activity is required
to stimulate CaV2.1, the effect of LRRK2 kinase inhibition
was investigated. HEK293 cells co-expressing all three CaV2.1
subunits with either wt or G2019S LRRK2 were pre-treated
with LRRK2-IN-1, an inhibitor of both wt and G2019S LRRK2
kinase activity (Deng et al., 2011). Whole cell CaV2.1 current
density was then measured and compared to control cells
pre-treated with DMSO vehicle. LRRK2 transfected cells pre-
treated with vehicle had similar increases in CaV2.1 current
density (Figure 5A) to LRRK2 alone (Figure 1C) demonstrating
DMSO did not impact on the stimulatory effect of LRRK2.
In contrast, cells that had been pre-treated with LRRK2-IN-
1 had reduced CaV2.1 current densities (Figure 5A) which
were comparable to cells expressing CaV2.1 alone (Figure 1C).
LRRK2-IN-1 pre-treatment caused a significantly reduced peak
CaV2.1 current density of −8.74 ± 2.71 pA/pF (n = 10)
compared to−24.53± 4.36 pA/pF (n= 10) in vehicle pre-treated
controls (Figure 5B).
We also investigated whether LRRK2-IN-1 could reverse the
stimulatory effects of the G2019S mutant on CaV2.1 function.
Figure 5A demonstrates that whole cell CaV2.1 current density
in G2019S LRRK2 transfected cells pre-treated with LRRK2-
IN-1 was reduced between the voltage range of 10–60 mV
compared to vehicle treated cells. A significant difference in
peak CaV2.1 current density was observed between LRRK2-IN-1
(−8.29± 1.86 pA/pF, n= 10) and vehicle (−35.51± 2.25 pA/pF,
n = 10) pre-treated cells (Figure 5B). Taken together, these
results indicate that the stimulatory effects of LRRK2 on CaV2.1
channels are dependent on the ability of LRRK2 to act as a kinase.
Importantly, LRRK2-IN-1 had no effect on CaV2.1 current
density in the absence of LRRK2 co-transfection as mean
CaV2.1 current density was similar between cells tranfected with
CaV2.1 channels and pre-treated with LRRK2-IN-1 or DMSO
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FIGURE 3 | Effect of LRRK2 on CaV2.1 activation and inactivation properties. (A) Voltage dependence of activation curves were recorded from HEK293 cells
transfected with CaV2.1 channels alone (black circles; n = 8 cells from four independent experiments) or co-transfected with LRRK2 (white triangles; n = 9 cells from
four independent experiments). (B) LRRK2 significantly decreased the Vhalf of CaV2.1 activation compared to control cells (where ∗∗ indicates p < 0.01; unpaired
t-test). (C) Voltage dependence of steady-state inactivation curves from HEK293 cells transfected with CaV2.1 channels alone (solid circles) or co-transfected with
LRRK2 (open triangles; n = 6 cells from three independent experiments). (D) LRRK2 had no significant effect on the Vhalf of CaV2.1 steady-state inactivation
compared to control cells. (E) Voltage dependence of activation curves were recorded from HEK293 cells transfected with CaV2.1 channels alone (black circles) or
co-transfected with LRRK1 (gray triangles; n = 10 cells from four independent experiments). (F) LRRK1 had no significant effect on the Vhalf of CaV2.1 activation
compared to control cells.
(Figures 5C,D). This confirms that the effects of the inhibitor are
specific to LRRK2 and are not caused by non-specific effects on
the channel directly or other channel regulatory proteins.
Next, we investigated the effect that LRRK2-IN-1 had on
activation kinetics of CaV2.1 channels in cells transfected with
LRRK2 and G2019S. Figure 6A illustrates that LRRK2-IN-1
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FIGURE 4 | The G2019S LRRK2 mutant causes an additional increase in CaV2.1 current density. (A) Mean I-V relationships of peak Ca2+ current density
from HEK293 cells transfected with CaV2.1 channels alone (solid circles; n = 10 cells from four independent experiments) or co-transfected with wt LRRK2 (white
triangles; n = 9 cells from four independent experiments) or G2019S LRRK2 (crosses; n = 9 cells from four independent experiments). (B) Mean peak Ca2+ current
density at a holding potential of 20 mV in cells expressing CaV2.1 alone, co-expressing wt LRRK2 or co-expressing G2019S LRRK2. (C) Voltage dependence of
activation curves were recorded from HEK293 cells transfected with CaV2.1 channels alone (black circles) or co-transfected with G2019S LRRK2 (crosses; n = 9
cells from four independent experiments). (D) G2019S LRRK2 significantly decreased the Vhalf of CaV2.1 activation compared to control cells (where ** indicates
p < 0.01; unpaired t-test). (E) HEK293 were transfected with EV, CaV2.1 channel subunits alone or plus wt LRRK2 or G2019S LRRK2. The expression of α1A, wt
LRRK2 or G2019S LRRK2 was evaluated by western-blotting. (F) The graph reports LRRK2 (black bars) and CaV2.1 α1A subunit (red bars) protein level normalized
vs. actin level. Data are expressed as mean ± SEM, (n = 8).
shifts the voltage-dependent activation curves of both LRRK2
and G2019S cells to more depolarized potentials compared to
DMSO treated controls. In cells transfected with LRRK2 and
pre-treated with DMSO, the mean half-activation voltage was
14.08 ± 1.2 mV (n = 9), significantly more hyperpolarized
than the value of 20.98 ± 1.7 mV (n = 9) obtained from
LRRK2-IN-1 pre-treated cells (Figure 6B). In addition, LRRK2-
IN-1 pre-treatment significantly depolarized the half-activation
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FIGURE 5 | Inhibition of LRRK2 prevents effect on CaV2.1 current density. (A) Mean I-V relationships of peak Ca2+ current density from HEK293 cells
co-transfected with CaV2.1 and LRRK2 pre-treated with vehicle (white triangles) or the LRRK2 inhibitor LRRK2-IN-1 (gray circles; n = 10 cells from four independent
experiments). Also shown are mean I-V relationships of cells co-transfected with CaV2.1 channels and G2019S pre-treated with vehicle (crosses) or LRRK2-IN-1
(black circles; n = 10 cells from four independent experiments). (B) LRRK2-IN-1 treated cells had a significantly reduced peak Ca2+ current density compared to
vehicle (where ∗∗ indicates p < 0.01) while peak Ca2+ current density in G2019S cells was still significantly elevated over LRRK2 cells pre-treated with vehicle (where
∗ indicates p < 0.05) and significantly reduced by LRRK2-IN-1 pre-treatment (where ∗∗ indicates p < 0.01; one-way ANOVA). (C) LRRK2-IN-1 pre-treatment (gray
circles) had no effect on CaV2.1 current density in the absence of exogenous LRRK2 expression compared to vehicle treated controls (black circles; n = 10 cells
from four independent experiments). (D) Peak Ca2+ current density was comparable between LRRK2-IN-1 pre-treated cells compared to vehicle controls.
voltage of G2019S transfected cells to 22.24 ± 3.3 mV (n = 8)
from a mean value of 11.60 ± 2.7 mV (n = 9; Figure 6B).
This data indicates that phosphorylation activity of LRRK2 is
required to affect changes in activation gating of the CaV2.1
channel. To rule out the possibility that LRRK2-IN-1 acts
directly on the CaV2.1 channel to alter gating, we examined
the effect of LRRK2-IN-1 on voltage-dependent activation of
CaV2.1 channels in the absence of exogenous LRRK2 expression.
Results from these experiments show that LRRK2-IN-1 has
no effect on either the voltage-dependent activation curve
(Figure 6C) or the half-inactivation voltage (Figure 6D). Overall,
these results indicate that the kinase activity of LRRK2 is
required to mediate changes in the activation gating of CaV2.1
channels.
LRRK2 Interacts with CaV2.1 Channels
The function of CaV channels can be modulated by regulatory
proteins directly interacting with channel subunits (Kiyonaka
et al., 2007; Jiang et al., 2008). Since LRRK2 has been
shown to interact with a number of presynaptic proteins
(Piccoli et al., 2011, 2014), we investigated whether LRRK2
interacts with CaV2.1 channel subunits as a mechanism to
control channel function. To this aim, we immunoprecipitated
endogenous LRRK2 from protein extracted from wt mouse
forebrain specimen previously exposed to a cross-linking
protocol. Interestingly, we noticed that rat anti LRRK2 but
not generic rat IgG precipitates endogenous LRRK2 and the
CaV channel β3 subunit but not the CaV channel α1 subunit
or SP6 ribosomal protein (Figure 7A). We obtained a similar
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FIGURE 6 | Effect of LRRK2-IN-1 on CaV2.1 activation properties. (A) Voltage dependence of activation curves were recorded from HEK293 cells transfected
with CaV2.1 channels plus LRRK2 and pre-treated with LRRK2-IN-1 (gray circles) or DMSO vehicle (white triangles; n = 9 cells from four independent experiments).
A separate group was co-transfected with G2019S and pre-treated with LRRK2-IN-1 (black circles) or DMSO (crosses; n = 9 cells from four independent
experiments). (B) LRRK2-IN-1 significantly increased the Vhalf of CaV2.1 activation in both LRRK2 and G2019S cells compared to control cells (where ∗ indicates
p < 0.05; one-way ANOVA). (C) Voltage dependence of activation curves from HEK293 cells transfected with CaV2.1 channels alone and pre-treated with DMSO
(solid circles) LRRK2-IN-1 (gray circles; n = 10 cells from four independent experiments). (D) LRRK2-IN-1 had no significant effect on the Vhalf of CaV2.1 activation
compared to control cells.
outcome by immunoprecipitating LRRK2 protein from mouse
forebrain specimen obtained from BAC hG2019S LRRK2
mice indicating that β3 interacts also with G2019S LRRK2,
even though to a significantly reduced extent compared to
wt LRRK2 (Figures 7B,C). All together, these data suggest
that LRRK2 specifically interacts with the CaV2.1 channel β3
subunit.
Endogenous CaV Channel Function is Also
Increased by LRRK2
Having established that LRRK2 regulates the function of
recombinant CaV2.1 channels, we next investigated whether
native CaV channels were also subjected to regulation by LRRK2
using the neuroendocrine rat pheochromocytoma PC12 cell line.
PC12 cells endogenously express a diversity of CaV channels
including CaV1.2, CaV1.3, CaV2.1 and CaV2.2 (Plummer et al.,
1989; Liu et al., 1996). To determine whether these native CaV
channels were modulated by LRRK2, we transfected PC12 cells
with wt LRRK2 plus GFP or GFP alone. Ba2+ was used as the
charge carrier to measure CaV currents in PC12 cells given its
higher permeability since endogenous levels of CaV channels
were expected to be much smaller than in our heterologous
expression system. Indeed, representative Ba2+ current traces
recorded from PC12 cells show that GFP-transfected cells have
small inward Ba2+ currents (Figure 8A). However, these currents
still exhibit the characteristic steep increase between the voltages
of −10 to 40 mV typical of high voltage activated Ca2+ channels
(Figure 8B). LRRK2 transfection increased the relative amount
of current (Figures 8B–D) in this voltage range while GFP
transfection had no effect compared to non-transfected controls
(Figure 8D). Interestingly, LRRK2 transfection also caused a
hyperpolarizing shift in the voltage at which the peak inward
Ba2+ current was recorded, from −20 to −10 mV (Figure 8B).
On average, LRRK2 transfection caused a significant increase
in peak current density at 20 mV from −1.86 ± 0.26 pA/pF
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FIGURE 7 | LRRK2 interacts with the CaV2.1 channel. (A) Mouse forebrain specimens obtained from littermate wt and heterozygous BAC hG2019S (GS) mice
were cross-linked and then processed for immunoprecipitation with rat anti LRRK2 antibodies. Eluted proteins were resolved by SDS-PAGE and detected with anti
LRRK2, anti CaV2.1 β3 subunit antibodies, anti CaV2.1 α1a and anti S6 ribosomal protein (S6RP). (B,C) The graphs report the yield of protein recovered upon
LRRK2 immunoprecipitation expressed as a percentage of relative input (B) and as amount of pulled CaV2.1 β3 subunit relative to the amount of pulled LRRK2 (C).
Bars represent mean ± SEM (n = 4) where * indicates p < 0.05; unpaired t-test.
(n = 9) in GFP transfected cells to −2.90 ± 0.24 pA/pF (n = 7)
in LRRK2 cells (Figure 8C). No significant difference in peak
Ba2+ current density was detected between non-transfected
and GFP transfected cells (Figure 8C). To determine whether
G2019S LRRK2 also stimulates endogenous CaV channels, whole
cell Ba2+ currents were measured in PC12 cells transfected
with GFP or G2019S plus GFP. Similar to the effect of wt
LRRK2, G2019S caused a large increase in current compared
to controls (Figure 8E). In contrast however, there was no
apparent shift in the voltage at which peak Ba2+ current was
recorded (Figure 8E). This peak current density was at 20 mV
where G2019S transfection caused an increase in current from
−1.81 ± 0.33 pA/pF (n = 10) in GFP transfected cells to
−3.98± 0.73 pA/pF (n= 10; Figure 8F). Finally, to investigate a
role for endogenous LRRK2 in regulating native CaV channels
in PC12 cells, we transfected cells with a LRRK2 silencing
construct we had previously used to knockdown LRRK2 in
cortical neurons (Piccoli et al., 2011). Figure 9A demonstrates
that siLRRK2 cells had reduced Ba2+ currents across several
voltages compared to control cells transfected with the EV
as performed previously. Peak Ba2+ currents at 20 mV were
significantly reduced in siLRRK2 cells (Figure 9B) indicating
that endogenous LRRK2 has a physiological role in controlling
activity of native CaV channels in PC12 cells. Endogenous
LRRK2 protein expression was confirmed in control PC12
cells (Figure 9C) which was significantly reduced in siRNA
treated cells (Figure 9D). Taken together, these results suggest
that, in addition to stimulating recombinant CaV2.1 channels,
LRRK2 is able to up-regulate activity of native CaV channels.
The fact that PC12 cells express a variety of different CaV
channel classes suggests that the effect of LRRK2 is not limited
to CaV2.1 alone but may also stimulate other CaV channel
types.
DISCUSSION
CaV2.1 channel activity is regulated by a diversity of kinases and
other signaling proteins to control Ca2+ influx and subsequent
Ca2+-dependent cellular functions. Here, we demonstrate for the
first time that LRRK2 can modulate CaV2.1 channel function
by causing a large increase in Ca2+ current. This effect was
associated with altered CaV2.1 activation properties and was
dependent on the kinase activity of LRRK2. These functional
effects may be a consequence of a physical interaction between
LRRK2 and the β3 subunit. Furthermore, LRRK2 also up-
regulated endogenous CaV channel activity suggesting that
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FIGURE 8 | Endogenous CaV channels are stimulated by LRRK2 in PC12 cells. Representative whole cell Ba2+ currents recorded from PC12 cells transfected
with GFP alone (A) or together with LRRK2 (B). (C) Mean I-V relationships of peak Ba2+ current density from non-transfected (gray circles), GFP transfected (black
circles) or LRRK2 transfected PC12 cells (white triangles; n = 7–9 from four independent experiments). (D) Mean peak Ba2+ current density at a holding potential of
20 mV in PC12 cells transfected as described in (C) where ∗∗ indicates p < 0.01, one-way ANOVA. (E) The effect of G2019S LRRK2 (crosses) on CaV current
density compared to GFP controls (circles; n = 10 cells from four independent experiments). (F) Peak Ba2+ current density was significantly elevated in G2019S
LRRK2 cells compared to vehicle controls (where ∗∗ indicates p < 0.01; unpaired t-test).
LRRK2 may have broad effects on a variety of different CaV
channels. Altogether, these results describe a novel regulatory
mechanism of CaV2.1 channels that is likely to play important
roles in both the physiology and pathophysiology of cellular Ca2+
signaling.
Several protein kinases have been shown to target CaV2.1
channels to modulate Ca2+ entry. PKC phosphorylates the I-II
linker region of the CaV2.1 α1A subunit to increase CaV2.1
current by antagonizing G-protein inhibition of the channel
(Zamponi et al., 1997). CaMKII also enhances Ca2+ entry but
does so by directly binding to the C-terminus of CaV2.1 to
slow inactivation kinetics and cause a depolarizing shift in
the voltage-dependence of inactivation (Jiang et al., 2008). In
contrast, both Cdk-5 (Tomizawa et al., 2002) and GSK-3 (Zhu
et al., 2010) have a negative effect on CaV2.1 function by
phosphorylating the II-III loop of CaV2.1 α1A subunit to prevent
SNARE protein interactions. Therefore, kinases utilize a range
of mechanisms to exert either stimulatory or inhibitory effects
on CaV2.1 function. In the present study, we have demonstrated
that LRRK2 stimulates CaV2.1 channels causing an increase
in Ca2+ current density. The mechanism behind this effect
appears to be due to a direct effect of LRRK2 on modulating
channel gating. This direct action of LRRK2 is supported
by our results showing that voltage-dependent activation is
significantly shifted to more hyperpolarized potentials with
LRRK2 overexpression. This would increase the proportion
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FIGURE 9 | Knockdown of endogenous LRRK2 in PC12 cells decreases native CaV channel function. (A) Silencing LRRK2 (white circles) reduces CaV
current density compared to LVTH controls (solid circles; n = 10 cells from four independent experiments). (B) Peak Ba2+ current density was significantly decreased
in siLRRK2 cells compared to controls (where ∗ indicates p < 0.05; unpaired t-test). (C) PC12 cells were transfected with LVTH control (ctrl) vector or siLRRK2 vector
and the expression of LRRK2 and β-actin was evaluated by western blotting. (D) The graph reports the LRRK2 protein level normalized to β-actin. Data are
expressed as mean ± SEM (n = 4; where ∗∗ indicates p < 0.01; unpaired t-test).
of active channels at more hyperpolarized voltages, leading
to an increased current density. This indicates that LRRK2
is impacting how the channel changes conformation at the
membrane in response to voltage; an effect most likely to be
caused by LRRK2 interacting with the macromolecular CaV2.1
complex. Moreover, our co-immunoprecipitation results reveal
that LRRK2 interacts with the CaV2.1 β3 subunit. Although it
is possible this could involve indirect associations via secondary
or tertiary binding relationships, this is unlikely here as we
were unable to co-immunoprecipitate the β3 interacting α1A
subunit. Therefore, since β3 subunits significantly affect voltage-
dependent activation (Sandoz et al., 2001; He et al., 2007),
we propose that LRRK2 is exerting an effect on this mode
of CaV2.1 channel gating through its interaction with the
β3 subunit. This is in agreement with the effects of another
presynaptic protein, RIM1 (Kiyonaka et al., 2007), which has
been shown to interact with CaV β subunits to augment CaV
channel function. Interestingly, the effects of RIM1 binding
on CaV2.1 properties depended on the type of β subunit
expressed. With β3, RIM1 slowed inactivation kinetics and
shifted the voltage-dependence of inactivation but had no effect
on current density or voltage dependence of activation (Kiyonaka
et al., 2007). This is in agreement with our findings of a β
interacting protein altering some channel functions but not
others. Taken together, our results support a direct role of
LRRK2 as a CaV channel regulatory protein interacting with
the β3 subunit to alter gating as a means to enhance CaV2.1
function.
Alternatively, LRRK2 could exert an increase in CaV2.1
current density by increasing channel numbers at the membrane.
Increasing the translation and synthesis of CaV2.1 channel
subunits is one potential mode for how LRRK2 might influence
channel numbers. This is supported by a recent study showing
LRRK2 phosphorylates the ribosomal protein s15 to increase
mRNA translation (Martin et al., 2014). In addition, increased
CaV2.1 channel numbers may be caused by LRRK2 regulating
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trafficking pathways responsible for determining the amount
of CaV2.1 at the plasma membrane. In this scenario, LRRK2
interactions with the β subunit could be important as trafficking
of the CaV channel complex from the endoplasmic reticulum to
the plasma membrane is dependent on β subunits (Altier et al.,
2011; Waithe et al., 2011). Furthermore, LRRK2 has been shown
to affect a variety of intracellular trafficking pathways to control
themembrane expression of several different cell surface proteins
(Migheli et al., 2013; Cho et al., 2014; Gómez-Suaga et al., 2014).
However, given that G2019S LRRK2 seems to bind the CaV2.1
β3 subunit to a lesser extent, channel trafficking may not be the
main target of LRRK2 activity.
A further insight into a potential mechanism is provided
by our results which demonstrate that LRRK2 is required to
phosphorylate a substrate in order to regulate CaV2.1 activity.
The G2019S LRRK2 mutant that has enhanced kinase activity
caused a more pronounced effect on CaV2.1 function while
blocking both wt and mutant LRRK2 kinase activity with
a LRRK2 inhibitor reversed these stimulatory effects. One
possible interpretation of these results is that LRRK2 needs to
autophosphorylate to become activated and initiate downstream
effects on CaV2.1 channels. This is supported by recent studies
demonstrating that LRRK2 autophosphorylation is required
for activation of LRRK2 GTPase activity that then influences
interactions with LRRK2 substrates (Cirnaru et al., 2014; Law
et al., 2014; Liu et al., 2016). Alternatively, LRRK2 could
be directly phosphorylating CaV2.1 proteins to alter channel
function. Indeed, two of the CaV2.1 channel subunits used
in this study (α1A and β3) have been shown to be directly
phosphorylated by other serine/threonine kinases (Zamponi
et al., 1997; Grueter et al., 2008; Jiang et al., 2008). A direct
role for LRRK2 phosphorylating CaV2.1 subunits is more
likely than indirect effects on CaV regulatory proteins given
that experiments were performed in a heterologous expression
system, however, further investigation is required to precisely
identify substrates of LRRK2 phosphorylation that lead to
increased CaV2.1 channel function.
While both wt LRRK2 and the G2019S mutant appear to up-
regulate CaV2.1 function by the same mechanism, this was a
specific effect of this particular kinase as we found that LRRK1
had no effect on CaV2.1 current. Therefore, the fact that LRRK1
and LRRK2 share similar leucine-rich-repeat, GTPase and kinase
domains but have divergent effects on CaV2.1 channels indicates
that the mode of regulation must be uniquely intrinsic to LRRK2
and is not a general effect of a common domain interaction.
This is in agreement with other LRRK2 specific effects where
increasing evidence suggests these two related proteins perform
distinct cellular functions by interacting with different proteins
(Reyniers et al., 2014).
Interestingly, the effect of LRRK2 may not be specific to
CaV2.1 channels only. We found that LRRK2 was able to up-
regulate endogenous CaV current in PC12 cells that contain
a variety of different types of CaV channels. Within this
background of multiple types of CaV channel subunits, it was not
possible here to discern if LRRK2 mediated increases in PC12
CaV current density involved alterations to activation gating.
However, these results provide evidence that several types of CaV
channels could be targeted by LRRK2. Future studies are required
to identify which other types of CaV channels are targeted by
LRRK2, the subunits involved and whether LRRK2 utilizes a
common mechanism to upregulate CaV function as we have
described here. If so, this would suggest that LRRK2 is involved
in a general physiological role of stimulating CaV channel
function to influence intracellular Ca2+ signaling. This could
have important downstream effects on many Ca2+ dependent
cellular processes such as vesicle trafficking and autophagy. In
fact, accumulating evidence describes a role for LRRK2 at the
presynaptic site. For example, we have previously shown that
LRRK2 influences neurotransmission acting as a scaffolding
element (Piccoli et al., 2011, 2014) as well as a kinase (Cirnaru
et al., 2014). If, as we have shown here in a recombinant system,
synaptic calcium channels are upregulated by LRRK2, it might
be expected that stimulus evoked neurotransmitter release would
be increased by LRRK2 activity and further by gain-of-function
mutations such as G2019S. Notably, complementary G2019S
models suggest that the gain-of-function LRRK2 mutation
positively modulates presynaptic release; in particular, LRRK2
knock-in mouse G2019S mutants are characterized by elevated
glutamate release and synaptic transmission (Beccano-Kelly
et al., 2014), primary cultures from BAC hG2019S mice
demonstrate increased synaptic vesicle trafficking (Belluzzi et al.,
2016) and G2019S over-expression in PC12 cells increases
dopamine release (Migheli et al., 2013). Indeed, we and others
have shown that reducing LRRK2 expression has a similar
impact on presynaptic properties (Piccoli et al., 2011; Matta
et al., 2012) with contrasting effects also reported (Arranz et al.,
2015). However, it is possible that LRRK2 plays different roles
while acting as a scaffold or a kinase. An intriguing hypothesis
is that LRRK2 may organize a molecular hub that impairs
neurotransmission by tethering synaptic vesicles via protein-
protein interactions (Piccoli et al., 2014). LRRK2 kinase activity
may instead promote synaptic vesicle fusion via phosphorylation
of presynaptic substrates such as snapin (Yun et al., 2013),
EndophilinA (Matta et al., 2012) N-ethylmaleimide sensitive
fusion (NSF; Belluzzi et al., 2016) and CaV2.1 channels (this
study). Given this dual role, any perturbation to LRRK2 levels or
kinase activity may influence LRRK2 control of synaptic calcium
channels and vesicle dynamics and, ultimately, on downstream
neurotransmission.
The effects of LRRK2 on CaV channels may be part of a
broader role of LRRK2 in regulating Ca2+ signaling proteins
as LRRK2 has been shown to activate NAADP receptors to
cause Ca2+ efflux from Ca2+ stores (Gómez-Suaga et al., 2012)
and stimulate Na+/Ca2+ exchanger activity (Yan et al., 2015).
In addition to a potential role in normal Ca2+ signaling,
our results may also provide further insight into LRRK2
pathophysiology. The G2019S LRRK2 mutation associated with
Parkinson’s disease stimulated CaV2.1 channels to a greater
degree than wt. This mutation has also been shown to cause
mitochondrial degradation in cortical neurons which could be
prevented by blocking Ca2+ influx via CaV channels (Cherra
et al., 2013). Therefore, LRRK2 mutations could disrupt normal
Ca2+ signaling as an early cellular event in the development of
Parkinson’s disease.
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In conclusion, this study has identified a novel role for
LRRK2 in regulating CaV2.1 channel function. Both wt and
mutant LRRK2 augment CaV2.1 function that is dependent on
kinase activation. This was associated with LRRK2 interacting
with the CaV β3 subunit. Although further investigation is
required to determine whether this involves LRRK2 directly
phosphorylating CaV subunits or having an indirect effect on
channel regulatory proteins, our results provide further evidence
that LRRK2 has an important regulatory role in cellular Ca2+
signaling.
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